Burney Co. Sells 923 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Burney Co. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the fourth quarter, Holdings Channel reports. The firm owned 42,032 shares of the healthcare conglomerate’s stock after selling 923 shares during the period. UnitedHealth Group accounts for approximately 0.8% of Burney Co.’s holdings, making the stock its 28th largest position. Burney Co.’s holdings in UnitedHealth Group were worth $21,262,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Delta Financial Group Inc. increased its position in shares of UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after purchasing an additional 17 shares during the last quarter. First PREMIER Bank increased its position in shares of UnitedHealth Group by 7.0% during the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after purchasing an additional 18 shares during the last quarter. Genesee Capital Advisors LLC increased its position in shares of UnitedHealth Group by 1.9% during the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock worth $579,000 after purchasing an additional 18 shares during the last quarter. Jmac Enterprises LLC increased its position in shares of UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after purchasing an additional 18 shares during the last quarter. Finally, Matrix Private Capital Group LLC increased its position in shares of UnitedHealth Group by 3.6% during the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock worth $276,000 after purchasing an additional 19 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 0.1 %

UNH opened at $543.21 on Thursday. The business’s 50-day simple moving average is $554.45 and its 200-day simple moving average is $563.12. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a market capitalization of $499.91 billion, a P/E ratio of 35.39, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the firm earned $6.56 earnings per share. The business’s revenue was up 9.2% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the stock. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Oppenheimer boosted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, UBS Group decreased their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and three have given a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.